The 24 February 2026 ARCS Regulatory Affairs Summit brought RA professionals together for a practical, conversation‑focused day exploring the real regulatory challenges facing Australian and New Zealand sponsors. Discussions centred on AI in RA, the NZ Medicines Amendment Act 2025, regulatory sandboxes, and the upcoming TGO 91/92 labelling changes. The key insights from these sessions will be shared with the wider RA community during the ARCS RA Interest Area Webinar on 23 March 2026.
David Ngo, Regulatory Affairs Manager, ANZ AbbVie Pty Ltd
Dr. Elaine Blair, Senior Director, Regulatory Affairs APAC, PTC Therapeutics Australia
Katrina Robins, Senior Regulatory Associate, Global Regulatory Sciences, Pfizer
ARCS Interest Area meetings serve as dynamic and collaborative webinars where professionals and experts come together to explore and discuss the latest trends, challenges, and innovations within our respective fields. While we're currently in the process of finalising the details, including the specific topic and esteemed speakers, we can assure you that this webinar will offer valuable insights and the chance to connect with like-minded individuals who share your passion and expertise.
ARCS Member - FREE
Non-member - FREE
%20(2).jpg)
-%20Ausbiotech24.jpg)
